Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
FibroScan - Because liver health matters
Frontiers | Liver Steatosis: Better Predictor of CKD in MAFLD Than Liver Fibrosis as Determined by Transient Elastography With Controlled Attenuation Parameter
Transient elastography versus liver biopsy: discordance in evaluations for fibrosis and steatosis from a pathology standpoint | Modern Pathology
Diagnostics | Free Full-Text | Ultrasound-Based Diagnostic Methods: Possible Use in Fatty Liver Disease Area
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Pa
Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery | Scientific Reports
JKMS :: Journal of Korean Medical Science
The diagnostic conundrum in non-alcoholic fatty liver disease
Diagnostics | Free Full-Text | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan
Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis - eClinicalMedicine
CAP cutoff values for the diagnosis of steatosis grades ≥S1, ≥S2, and ≥S3 | Download Table
FibroScan - Because liver health matters
Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study
FibroScan - Because liver health matters
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease - ScienceDirect
Non-invasive tests of non-alcoholic fatty liver disease | Chinese Medical Journal
Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter - ScienceDirect
Estimation of Liver Fat by FibroScan in Patients With Nonalcoholic Fatty Liver Disease | Metrics - Cureus
Presentación de PowerPoint
General Brochure_FibroScan_EN
Clinical and Molecular Hepatology
